Literature DB >> 2692563

Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins.

T Kinoshita1, K Tashiro, T Nakamura.   

Abstract

When experimental hepatitis was induced by administrating rats with hepatotoxins such as CCl4 and D-galactosamine, HGF mRNA increased dramatically in the injured liver. The increase of HGF mRNA was time- and dose-dependent. At 5 hr after CCl4-treatment, HGF mRNA was remarkably increased; it reached the maximum level at 10 hr and maintained at this level for 40 hr. On the contrary, in D-galactosamine-induced hepatitis, HGF mRNA started to increase from 24 hr after a long lag time. Moreover, HGF mRNA was expressed transiently, decreasing rapidly to the basal level after reaching the maximum level at 36 hr. The degree of induction of HGF mRNA correlates well to the degree of liver damage. In the liver, HGF mRNA could be detected in only non-parenchymal cells, not in parenchymal hepatocytes. These findings suggest that liver is a main producing organ of HGF for liver regeneration after hepatic injury, and HGF is synthesized and secreted by non-parenchymal liver cells so that it stimulates the growth of parenchymal hepatocytes to repair liver tissue in paracrine fashion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692563     DOI: 10.1016/0006-291x(89)92733-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat.

Authors:  P Pediaditakis; J C Lopez-Talavera; B Petersen; S P Monga; G K Michalopoulos
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

2.  Identification of mannose receptor as receptor for hepatocyte growth factor β-chain: novel ligand-receptor pathway for enhancing macrophage phagocytosis.

Authors:  Hiroyuki Ohnishi; Kiyomasa Oka; Shinya Mizuno; Toshikazu Nakamura
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

3.  Synaptophysin: A novel marker for human and rat hepatic stellate cells.

Authors:  D Cassiman; J van Pelt; R De Vos; F Van Lommel; V Desmet; S H Yap; T Roskams
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

Review 5.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

6.  Growth factors and the liver.

Authors:  A C Selden; H J Hodgson
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

7.  A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

Authors:  J S Rubin; A M Chan; D P Bottaro; W H Burgess; W G Taylor; A C Cech; D W Hirschfield; J Wong; T Miki; P W Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 8.  Liver regeneration in relationship to acute liver failure.

Authors:  C D Gove; R D Hughes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

9.  Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride.

Authors:  J J Maher
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

10.  Expression of HGF and TGF-beta 1 mRNA after partial hepatectomy in rats with liver cirrhosis.

Authors:  S Mitsue; M Hamanoue; G Tanabe; Y Ogura; S Yoshidome; T Aikou; T Nakamura
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.